High Accuracy Bnp/Brain Natriuretic Peptide Rapid Quantitative Test Kit with CE, ISO13485

• Type: IVD Reagent
• Certification: CE, ISO13485
• Warranty: 2 Years
• Delivery Time: 7-15 Workdays
• Usage: Nt-Probnp Rapid Test
• Storage: 2-30ºC
• Model NO.: BNP-w/s/p-G
• Method: Fluorescence Chromatography
• Transport Package: Plastic Bag, Sealed Carton
• Specification: 300*60mm, 300*80mm Customized
• Trademark: SEKBIO/OEM
• Origin: Shenzhen, China
• HS Code: 3002150090
• Production Capacity: 1000000

Product Description

Product Description

BNP (B-type natriuretic peptide) is a cardiac biomarker primarily used to assess heart function and the severity of heart failure. It is released by    cardiac cells, particularly in cardiac damage or heart failure cases, and helps regulate fluid balance and blood pressure by promoting sodium excretion and vasodilation.

In clinical practice, measuring BNP levels in the blood helps healthcare providers:

• Confirm the diagnosis of heart failure
• Assess the severity of heart failure
• Monitor treatment effectiveness and disease progression

BNP is often measured alongside its precursor molecule, , both valuable in diagnosing and managing heart failure.

Linear

Cal	Concentration	Result	AVERAGE
S1	0.11	0.10	0.11
		0.10
		0.12
S2	0.53	0.53	0.52
		0.46
		0.58
S3	2.17	1.96	2.14
		2.28
		2.17
S4	10.1	9.28	10.64
		12.04
		10.59
S5	27.57	26.27	26.88
		27.66
		26.70
S6	39.32	41.69	42.73
		44.67
		41.82

 Precision

Cal	Concentration	Cal	Concentration	Cal	Concentration
R1	0.30	R2	2.12	R3	29.73
	0.28		1.90		29.36
	0.26		2.15		26.06
	0.30		2.34		25.94
	0.26		2.05		25.43
	0.24		1.96		30.11
	0.30		1.83		30.27
	0.29		2.07		25.48
	0.24		1.85		31.06
	0.32		2.12		27.73
AVE	0.28	AVE	2.04	AVE	28.12
SD	0.03	SD	0.16	SD	2.23
CV	9.7%	CV	7.7%	CV	7.9%

Method Comparison

 

 

Detailed Photos

 

1.  Main components:

Name	Quantity	Unit
Test card with desiccant in a sealed foil pouch	25	tests
Sample diluent	25	bottles
ID chip	1	pcs
Instruction for use	1	pcs

 

This test kit uses double antibody sandwich method  principle and fluorescence immunochromatography analysis technology to quantitatively detect the concentration of BNP antigen in human plasma or whole blood samples.

This product is pre-embedded with fluorescent microspheres labeled mouse anti-BNP antibody and rabbit IgG antibody on the binding pad, and coated with mouse anti-BNP antibody and goat anti-rabbit IgG antibody respectively on the test line and control line of  nitrocellulose membrane. When the sample is tested, the BNP antigen in the sample is combined with the fluorescent microspheres-labeled mouse anti-BNP antibody embedded on the conjugate pad to form the fluorescent  microspheres-labeled mouse anti-BNP antibody-BNP immune complex. Under the action of chromatography, the immune   complex flows along the nitrocellulose membrane to the end of the absorbent filter paper. On the test line, the immune  complex is captured by the mouse BNP antibody pre-coated, forming the double-antibody sandwich structure of fluorescent   microspheres labeled mouse anti-BNP antibody-BNP-mouse anti-BNP antibody and enriching. When the samples pass the  control line, the rabbit IgG antibody labeled with fluorescent particles is enriched by combining with the pre-coated goat  anti-rabbit IgG antibody. The concentration of BNP in the sample is positively correlated with the fluorescence intensity of the test line. The concentration of BNP in the sample is obtained through the test and analysis by the Immunofluorescence Analyzer.
 

• Positive Result: Visible lines at both the control line (C) and the test line (T) on the test device indicate a positive result for BNP. This suggests the presence of elevated BNP concentration in the sample. Clinical correlation with other symptoms and tests is recommended for further evaluation.

• Negative Result: Only the control line (C) is visible on the test device, with no line at the test region (T). This indicates a negative result for BNP, suggesting that BNP concentration was not detected in the sample. Clinical interpretation should consider additional diagnostic information.

• Invalid Result: No visible colored band appears at the control line (C) on the test device. Possible reasons include insufficient sample volume, incorrect procedural technique, or use of expired test devices. It is advised to review the testing procedure and repeat with a new test device.

REFERENCE INTERVAL
 

1.  Normal reference interval: 0~ 100pg/mL.

      2.  Due to differences in geography, ethnicity, and age, it is recommended that each laboratory establish a BNP reference interval with relevant clinical significance for the population of the region.

INTERPRETATION OF TEST RESULTS

Item name	Test results	Clinical application recommendations
BNP	0~ 100pg/mL	Normal level
	>100pg/mL	It indicates that the patient is at risk of congestive heart failure.

(The above is for reference only, not as clinical diagnostic criteria. The test results should be combined with other clinical symptoms and examination results.)


 

Product lists

Rapid test Kit-Colloidal gold
Chlamydia	C. pneumoniae	H. Pylori	Malaria
Rotavirus	Adenovirus	Rota/Adeno	Strep A
Syphilis	HBsAg	HBsAb	HBsAg and HCV
HBsAg /HCV /HIV /Syphilis	Dengue IgG/IgM	Dengue Ns1	Dengue IgG/IgM /NS1
Chikungunya	Cholera	Typhoid	Tuberculosis
HIV1+2	HIV1+2 Ag/Ab	SEA	ToRCH
HCV	HSV	RSV	TOXO
Rubella	CMV	Norovirus	Leishmania
Filariasis	Leptospira	Monkeypox	M.Pneumoniae
Chagas	Brucella	HPV
Influenza A+B	Influenza A+B	Influenza A+B/RSV	FOB
AMH	AMH/FSH	MxA	cTnI
HCG	LH	25-OH VD
The Customized cut -off and sizes are available

 

Lateral Flow Quantitive Test Kit
Class	Rapid Test	Sample type	Detection Range
Cardiac Marker	cTn I	Serum/Plasma/Whole blood	0.1~40 ng/mL
	NT-proBNP	Serum/Plasma/Whole blood	100~20000 pg/mL
	CK-MB	Serum/Plasma/Whole blood	1ng/mL~100ng/mL
	BNP	Plasma/Whole blood	5pg/mL~5000pg/mL
	cTnT	Serum/Plasma/Whole blood	30pg/mL~25000pg/mL
	Myo	Serum/Plasma/Whole blood	5ng/mL~500ng/mL
	cTnl/ Myo/ CK-MB	Serum/Plasma/Whole blood	cTnI: 0.1ng/mL~40ng/mL;Myo: 5ng/mL~500ng/mL;CK-MB: 1ng/mL~100ng/mL
	D-Dimer/ cTnI/ NT-proBNP	Serum/Plasma/Whole blood	Dimer: 0.1mg/L~10mg/L; cTnI: 0.1ng/mL~40ng/mL; NT-proBNP: 100pg/mL~20000pg/mL
Inflammatory	PCT	Serum/Plasma/Whole blood	0.1~100 pg/mL
	CRP	Serum/Plasma/Whole blood	0.5~200mg/L
	SAA	Serum/Plasma/Whole blood	5~300mg/L
	IL-6	Serum/Plasma/Whole blood	5~5000 pg/mL
	PCT/ IL-6	Serum/Plasma/Whole blood	PCT: 0.1ng/mL~100ng/mL;IL-6:10pg/mL~10000pg/mL
	CRP/ SAA	Serum/Plasma/Whole blood	CRP 0.5mg/L~200mg/L;SAA 5mg/L~300mg/L,
Glycated hemoglobin	HbA1c	Whole blood	3~14%
Tumor	PSA	Serum/Plasma/Whole blood	2~80 ng/mL
HCG	HCG	Serum/Plasma/Whole blood	5~200000mIU/mL
Anticoagulation	D-Dimer	Plasma/Whole blood	0.1~10 mg/L
Endocrine	TSH	Serum/Plasma/Whole blood	0.1mIU/L ~100.0mIU/L
	T3	Serum/Plasma/Whole blood	0.61~9.22 nmol/L
	T4	Serum/Plasma/Whole blood	12.87~310 nmol/L
	FT3	Serum/Plasma/Whole blood	0.60pmol/L ~45.00pmol/L
	FT4	Serum/Plasma/Whole blood	1.00pmol/L ~100.00pmol/L
	AMH	Serum/Plasma/Whole blood	0.1~16 ng/mL
	PROG	Serum/Plasma	0.35ng/mL~60ng/mL
	PRL	Serum/Plasma/Whole blood	1 ng/mL~200ng/mL
	FSH	Serum/Plasma/Whole blood	1mIU/mL~100 mIU/mL
	LH	Serum/Plasma/Whole blood	1 ~100 mIU/mL
	TES	Serum/Plasma	0.2~15  ng/mL
	E2	Serum/Plasma/Whole blood	15 pg/mL~3000pg/mL
Bone	25-OH-VD	Serum/Plasma/Whole blood	5.0ng/mL~100.0ng/mL
The Customized cut -off and size are available

 

Company Profile

Certifications

 

Packaging & Shipping